Fig. 8

In vivo antitumor activity of syringolin extracts. Treated BALB/c mice bearing 4T1 breast cancer tumor by gastric lavage (a), intratumoral injection (b), and intravenous injection (c). Syringolin-treated B16 murine melanoma model in C57BL/6 mice by intratumoral injection (d)